|
Volumn 43, Issue 4, 1996, Pages 340-341
|
Oral contraceptives and breast cancer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONTRACEPTIVE AGENT;
ORAL CONTRACEPTIVE AGENT;
ADULT;
ARTICLE;
BIOLOGY;
BREAST CANCER;
BREAST TUMOR;
CANCER;
CASE CONTROL STUDIES;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTRACEPTION;
CONTRACEPTIVE AGENTS, ESTROGEN;
CONTRACEPTIVE METHODS;
DEMOGRAPHIC FACTORS;
DISEASES;
FAMILY PLANNING;
FEMALE;
HUMAN;
META ANALYSIS;
METHODOLOGY;
NEOPLASM;
ORAL CONTRACEPTIVES;
ORAL CONTRACEPTIVES, COMBINED;
POPULATION;
POPULATION DYNAMICS;
REPRODUCIBILITY;
RISK;
RISK FACTOR;
STUDIES;
TIME;
BIOLOGY;
BREAST CANCER;
CANCER;
CASE CONTROL STUDIES;
COHORT ANALYSIS;
CONTRACEPTION;
CONTRACEPTIVE AGENTS;
CONTRACEPTIVE AGENTS, ESTROGEN;
CONTRACEPTIVE AGENTS, FEMALE;
CONTRACEPTIVE METHODS;
DEMOGRAPHIC FACTORS;
DISEASES;
FAMILY PLANNING;
NEOPLASMS;
ORAL CONTRACEPTIVES;
ORAL CONTRACEPTIVES, COMBINED;
POPULATION;
POPULATION DYNAMICS;
RESEARCH METHODOLOGY;
RISK FACTORS;
STUDIES;
TIME FACTORS;
ADULT;
BREAST NEOPLASMS;
CLINICAL TRIALS;
CONTRACEPTIVES, ORAL, COMBINED;
FEMALE;
HUMANS;
META-ANALYSIS;
REPRODUCIBILITY OF RESULTS;
RISK;
|
EID: 0030267834
PISSN: 00943509
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|